Immunotherapy and Biomarkers in Sarcoma

Sarcoma describes a rare and heterogeneous group of diseases. Current treatment options for metastatic sarcoma are quite limited. Conventional treatments with chemotherapy or anti-angiogenic agents result in a non-durable response and a survival rate of approximately 12 to 18 months. In addition, th...

Full description

Saved in:
Bibliographic Details
Main Author: Dajsakdipon T.
Other Authors: Mahidol University
Format: Review
Published: 2023
Subjects:
Online Access:https://repository.li.mahidol.ac.th/handle/123456789/86062
Tags: Add Tag
No Tags, Be the first to tag this record!
Institution: Mahidol University